Literature DB >> 23229349

Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study.

Quynh T Vo1, Christopher Cox, Xiuhong Li, Lisa P Jacobson, Rosemary McKaig, Ned Sacktor, Ola A Selnes, Eileen Martin, James T Becker, Eric N Miller.   

Abstract

The objective of this study is to compare neuropsychological test performance before and after HIV-1 seroconversion in order to identify possible acute changes in psychomotor speed, memory, attention, and concentration secondary to seroconversion. The study utilized mixed effects models to examine longitudinal neuropsychological test data. We conducted a nested cohort study of 362 male HIV-1 seroconverters enrolled in the Multicenter AIDS Cohort Study. We used linear mixed models with random subject effects to compare repeated neuropsychological test outcomes from 5 years before seroconversion to 2 years after seroconversion on the Trail Making Test (parts A and B), Symbol-Digit Test, Grooved Pegboard (dominant and non-dominant hands), Stroop Color-Interference Test, Rey Auditory Verbal Learning Test, and the CalCAP Reaction Time Test. We found no significant changes in the time-dependent score after seroconversion for the majority of neuropsychological tests used in the Multicenter AIDS Cohort Study. There was a significant change in time trend after seroconversion on part B of the Trail Making Test (p=0.042), but the difference only represented a 2 % decrease in performance. We found the following characteristics to be associated with worse neuropsychological test performance: lower education levels, history of depression, older age, and no previous neurocognitive testing (p< .05). Our results suggest that despite a 50 % decrease in CD4 cell count immediately following infection, HIV-1 does not appear to have a measurable effect on psychomotor or complex cognitive processing for up to 2 years following infection, using this set of neurocognitive measures.

Entities:  

Mesh:

Year:  2012        PMID: 23229349      PMCID: PMC3568242          DOI: 10.1007/s13365-012-0136-8

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  28 in total

1.  Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion.

Authors:  Thomas D Marcotte; Reena Deutsch; J Allen McCutchan; David J Moore; Scott Letendre; Ronald J Ellis; Mark R Wallace; Robert K Heaton; Igor Grant
Journal:  Arch Neurol       Date:  2003-10

2.  CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy.

Authors:  Ronald J Ellis; Jayraan Badiee; Florin Vaida; Scott Letendre; Robert K Heaton; David Clifford; Ann C Collier; Benjamin Gelman; Justin McArthur; Susan Morgello; J Allen McCutchan; Igor Grant
Journal:  AIDS       Date:  2011-09-10       Impact factor: 4.177

3.  Assessment of cognition using surveys and neuropsychological assessment: the Health and Retirement Study and the Aging, Demographics, and Memory Study.

Authors:  Eileen M Crimmins; Jung Ki Kim; Kenneth M Langa; David R Weir
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-07       Impact factor: 4.077

4.  Cognitive correlates of functional performance in older adults: comparison of self-report, direct observation, and performance-based measures.

Authors:  Maureen Schmitter-Edgecombe; Carolyn Parsey; Diane J Cook
Journal:  J Int Neuropsychol Soc       Date:  2011-06-27       Impact factor: 2.892

5.  Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.

Authors:  Linda Chang; Thomas Ernst; Mallory D Witt; Nina Ames; Megan Gaiefsky; Eric Miller
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

6.  Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study.

Authors:  P Vivithanaporn; G Heo; J Gamble; H B Krentz; A Hoke; M J Gill; C Power
Journal:  Neurology       Date:  2010-08-25       Impact factor: 9.910

7.  High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis.

Authors:  M C Zink; K Suryanarayana; J L Mankowski; A Shen; M Piatak; J P Spelman; D L Carter; R J Adams; J D Lifson; J E Clements
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 8.  Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinase.

Authors:  Harris A Gelbard; Stephen Dewhurst; Sanjay B Maggirwar; Michelle Kiebala; Oksana Polesskaya; Howard E Gendelman
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

9.  Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.

Authors:  Serena Spudich; Magnus Gisslen; Lars Hagberg; Evelyn Lee; Teri Liegler; Bruce Brew; Dietmar Fuchs; Giuseppe Tambussi; Paola Cinque; Frederick M Hecht; Richard W Price
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

10.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

View more
  10 in total

1.  Cognitive function in early HIV infection.

Authors:  Aanchal Prakash; Jue Hou; Lei Liu; Yi Gao; Casey Kettering; Ann B Ragin
Journal:  J Neurovirol       Date:  2016-11-28       Impact factor: 2.643

Review 2.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

3.  Self-initiated continuation of and adherence to HIV pre-exposure prophylaxis (PrEP) after PrEP demonstration project roll-off in men who have sex with men: associations with risky decision making, impulsivity/disinhibition, and sensation seeking.

Authors:  Martin Hoenigl; Erin Morgan; Donald Franklin; Peter L Anderson; Elizabeth Pasipanodya; Matthew Dawson; Marvin Hanashiro; Eric E Ellorin; Jill Blumenthal; Robert Heaton; David J Moore; Sheldon R Morris
Journal:  J Neurovirol       Date:  2019-01-07       Impact factor: 2.643

4.  Evidence for neuropsychological health disparities in Black Americans with HIV disease.

Authors:  Jennifer L Thompson; Ilex Beltran-Najera; Briana Johnson; Yenifer Morales; Steven Paul Woods
Journal:  Clin Neuropsychol       Date:  2021-07-10       Impact factor: 3.535

5.  Cognitive performance in a South African cohort of people with HIV and comorbid major depressive disorder.

Authors:  Anna J Dreyer; Sam Nightingale; Lena S Andersen; Jasper S Lee; Hetta Gouse; Steven A Safren; Conall O'Cleirigh; Kevin G F Thomas; John Joska
Journal:  J Neurovirol       Date:  2022-09-01       Impact factor: 3.739

6.  Cohort Profile: Recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study.

Authors:  James T Becker; Lawrence A Kingsley; Samantha Molsberry; Sandra Reynolds; Aaron Aronow; Andrew J Levine; Eileen Martin; Eric N Miller; Cynthia A Munro; Ann Ragin; Ned Sacktor; Ola A Selnes
Journal:  Int J Epidemiol       Date:  2014-04-24       Impact factor: 7.196

7.  Neurobehavioral Disturbances During Acute and Early HIV Infection.

Authors:  Rujvi Kamat; Katie L Doyle; Jennifer E Iudicello; Erin E Morgan; Sheldon Morris; Davey M Smith; Susan J Little; Igor Grant; Steven Paul Woods
Journal:  Cogn Behav Neurol       Date:  2016-03       Impact factor: 1.600

8.  Relationship between HIV stage and psychomotor speed neurocognitive score at a Kenyan sub-county hospital.

Authors:  Rachael N Kinuthia; Benson N Gakinya; Joseph M Thigiti
Journal:  Afr J Prim Health Care Fam Med       Date:  2016-08-31

9.  Neurocognitive performance differences between black and white individuals with HIV disease are mediated by health literacy.

Authors:  Ilex Beltran-Najera; Jennifer L Thompson; Anastasia Matchanova; Kelli L Sullivan; Michelle A Babicz; Steven Paul Woods
Journal:  Clin Neuropsychol       Date:  2021-07-26       Impact factor: 3.535

10.  Predictors of Improvement in Quality of Life When Treating Hypothyroidism.

Authors:  Bjarke Borregaard Medici; Jeppe Lerche la Cour; Filip Krag Knop; Martin Krakauer; Luba Freja Michaelsson; Jens Faber; Torquil Watt; Birte Nygaard
Journal:  J Thyroid Res       Date:  2021-06-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.